We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Automated Workflow Offers PCR-Based Molecular Diagnostic Assay Menu

By LabMedica International staff writers
Posted on 01 Sep 2010
A novel, integrated system sets new standards for molecular testing and incorporates all workflow steps from sample to detection.

The system offers features that create flexibility, such as continuous loading, random access, open channels for user-developed tests, and a very broad menu of commercial assays. More...
It has the ability to process an almost unlimited range of sample types and it should transform the laboratory's work in the emerging field of molecular diagnostic

This new and complete workflow solution is comprised of modules that can be used as standalone systems or combined into a fully integrated system. Called QIAsymphony RGQ, and introduced by Qiagen (Frankfurt, Germany), the system comprises the physical and data integration of the modules QIAsymphony SP for sample preparation, QIAsymphony AS for assay setup, and the Rotor-Gene Q real time polymerase chain reaction (PCR) thermocycler.

QIAsymphony provides the broadest available PCR-based assay menu, including the Artus real time PCR kits for the detection of human immunosuppression virus (HIV), Human hepatitis C and B viruses (HCV, HBV), and a transplantation panel with Cytomegalovirus (CMV), Epstein Bar virus (EBV), Herpes simplex virus (HSV), Varicella-Zoster (VZV) and BK virus (BKV1). (BK was the initials of the patient from whom the virus was first isolated).

A large pipeline of more tests will be launched in the coming months, including TheraScreen, epidermal growth factor receptor (EGFR), KRAS, as well as Artus Influenza, Computed tomography (CT), CT Neisseria gonorrhoeae (CT/Ng) and an extended transplantation panel. Many more tests are in development including integration of detection options such as pyrosequencing and multiplexing solutions.

Qiagen N.V., a Netherlands holding company, is a global provider of sample and assay technologies. Sample technologies are used to isolate and process DNA, RNA, and proteins from biological samples such as blood or tissue. Assay technologies are used to make such isolated bio-molecules visible.

Related Links:
Qiagen



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Electrolyte Analyzer
CBS-4000 (CBS-400)
Clinical Informatics Platform
CLARION™
New
Fully Automated Urinalysis System
DxU 1800 Fully Automated Urinalysis System
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Nian Sun has spent years perfecting a device that he believes could change the way diseases are detected. (Photo courtesy of Alyssa Stone/Northeastern University)

Rapid Breath Sensor Detects SARS-CoV-2 from Exhaled Air

Nasal swabs and polymerase chain reaction (PCR) testing have been central to identifying SARS-CoV-2, but they can be uncomfortable, slow, and logistically complex when samples require transport.... Read more

Molecular Diagnostics

view channel
Image: At the MHH Institute of Human Genetics: Prof. Dr. Doris Steinemann, Dr. Bernardus Aldrige Allister and Prof. Dr Monika Golas (from left). (Image Credit: Karin Kaiser/MHH)

Multi-Omics Analysis Identifies Additional Risk Genes in Hereditary Breast and Ovarian Cancer

Hereditary breast and ovarian cancer can be difficult to explain genetically, leaving many high-risk families without clear answers. Although 13 established risk genes, including BRCA1 and BRCA2, are routinely... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.